Johansen PB, Nowak J, Skjrbk C, Flyvbjerg A, Andreassen TT, Wilken M, et al
Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke
There is also increasing evidence that deregulation of GSH synthesis contributes to the pathogenesis of diseases such as diabetes mellitus, pulmonary and hepatic fibrosis, alcoholic liver disease, cholestatic liver injury, endotoxemia, and drug-resistant tumors cells [10]
On top of that, youll also get to see Alex shred on some (name brand!) Rollerblade inline skates
The most common criticism against GLP-1 users is that they're taking the "easy way out." This comes from a basic misunderstanding of obesity as a chronic disease, not a lack of discipline.10 It's crucial to remember that GLP-1s are medical treatments for a complex condition, similar to bariatric surgery, designed to address underlying biological mechanisms that make weight loss incredibly hard for many.10 The data clearly shows how common and where this shaming comes from 13 : Half of all people taking GLP-1 medication report experiencing judgment or shame
